Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K report on January 24, 2003, to announce its financial results for the quarter and full year ended December 31, 2002. The filing includes a press release detailing these results, which is the primary source of information for investors regarding the company's recent performance. This report serves as a notification of material information dissemination to the public, aligning with Regulation FD. Investors should refer to the attached press release (Exhibit 99.1) for specific financial figures, operational achievements, and any forward-looking statements or guidance provided by Quest Diagnostics for the period.
Key Highlights
- 1Quest Diagnostics Incorporated filed an 8-K report on January 24, 2003.
- 2The report's earliest event date is January 23, 2003.
- 3The purpose of the filing is to report on results for the quarter and year ended December 31, 2002.
- 4The filing includes a press release issued on January 23, 2003, as Exhibit 99.1.
- 5This disclosure complies with Regulation FD, ensuring timely public dissemination of material information.
- 6Investors need to consult Exhibit 99.1 for detailed financial and operational performance data.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce Quest Diagnostics' financial results for the quarter and full year ended December 31, 2002, as detailed in an accompanying press release.
The specific financial results, including earnings and other key metrics, are contained within the press release attached as Exhibit 99.1 to this 8-K filing.
The results were announced via a press release on January 23, 2003, and reported in this 8-K filing on January 24, 2003.
This 8-K filing itself primarily serves to report past results. Any information regarding new strategic initiatives or future guidance would be detailed in the press release (Exhibit 99.1) and should be reviewed for those specifics.